Clinical Trial Update: A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) [Phase 1]

View source ↗

Summary

Phase 1 trial studying whether nintedanib affects components of birth-control pills in women with systemic sclerosis-associated interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis-associated Interstitial Lung Disease

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Scleroderma, Systemic | Phase 1 | Status: COMPLETED | Results posted: 2020-11-09